Rankings
▼
Calendar
PCVX (Vaxcyte, Inc.) Stock Financials & Earnings | Market Cap Arena
PCVX
Vaxcyte, Inc.
Mkt Cap
$9B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$767M
EPS (TTM)
-$5.63
Free Cash Flow (TTM)
-$669M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$71M
Q2 23
$0
$0
-$87M
Q3 23
$0
$0
-$113M
Q4 23
$0
$0
-$197M
Q1 24
$0
$0
-$114M
Q2 24
$0
$0
-$153M
Q3 24
$0
$0
-$140M
Q4 24
$0
$0
-$162M
Q1 25
$0
$0
-$181M
Q2 25
$0
-$5M
-$226M
Q3 25
$0
$0
-$242M
Q4 25
$0
$5M
-$274M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$48M
-$53M
Q2 23
-$63M
-$61M
Q3 23
-$58M
-$65M
Q4 23
-$129M
-$186M
Q1 24
-$159M
-$171M
Q2 24
-$121M
-$167M
Q3 24
-$61M
-$99M
Q4 24
-$111M
-$141M
Q1 25
-$166M
-$193M
Q2 25
-$121M
-$102M
Q3 25
-$143M
-$155M
Q4 25
-$225M
-$219M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$6M
Q2 23
$2M
Q3 23
$7M
Q4 23
$57M
Q1 24
$12M
Q2 24
$45M
Q3 24
$38M
Q4 24
$30M
Q1 25
$27M
Q2 25
$20M
Q3 25
$12M
Q4 25
$6M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+81.5%
Q2 23
—
+82.0%
Q3 23
—
+93.0%
Q4 23
—
+127.2%
Q1 24
—
+60.8%
Q2 24
—
+75.5%
Q3 24
—
+23.8%
Q4 24
—
-17.5%
Q1 25
—
+57.9%
Q2 25
—
+47.9%
Q3 25
—
+73.2%
Q4 25
—
+69.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$10M
—
Q2 23
$13M
—
Q3 23
$13M
—
Q4 23
$13M
—
Q1 24
$18M
—
Q2 24
$22M
—
Q3 24
$21M
—
Q4 24
$24M
—
Q1 25
$31M
—
Q2 25
$37M
—
Q3 25
$35M
—
Q4 25
$36M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$58M
$13M
Q2 23
$73M
$14M
Q3 23
$97M
$16M
Q4 23
$104M
$18M
Q1 24
$95M
$20M
Q2 24
$132M
$21M
Q3 24
$117M
$23M
Q4 24
$134M
$29M
Q1 25
$148M
$33M
Q2 25
$194M
$32M
Q3 25
$210M
$32M
Q4 25
$242M
$32M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$380M
$442M
$822M
Q2 23
$531M
$756M
$1.3B
Q3 23
$545M
$721M
$1.3B
Q4 23
$397M
$683M
$1.1B
Q1 24
$612M
$875M
$1.5B
Q2 24
$519M
$934M
$1.5B
Q3 24
$1.1B
$1.1B
$2.2B
Q4 24
$388M
$1.4B
$1.7B
Q1 25
$347M
$1.3B
$1.7B
Q2 25
$307M
$1.4B
$1.7B
Q3 25
$281M
$1.4B
$1.7B
Q4 25
$174M
$1.4B
$1.6B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
86M
+14.1%
Q2 23
98M
+13.7%
Q3 23
102M
+3.7%
Q4 23
104M
+2.7%
Q1 24
112M
+7.0%
Q2 24
117M
+5.0%
Q3 24
124M
+5.5%
Q4 24
123M
-0.7%
Q1 25
136M
+10.5%
Q2 25
136M
+0.3%
Q3 25
136M
+0.1%
Q4 25
136M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
$0
58
FY 21
$0
89
FY 22
$0
158
FY 23
$0
254
FY 24
$0
414
FY 25
$0
507
marketcaparena.com